The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
|Articles|May 26, 2013
Supplements and Featured Publications
- Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye [CPE]
- Volume 19
- Issue 5 Suppl
Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye
Advertisement
Instructions
After reading “Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye,” complete the program evaluation and select the single best answer to each of the posttest questions.
A statement of continuing education credit will be provided to those pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.
Articles in this issue
over 13 years ago
Managed Care Implications of Age-Related Ocular Conditionsover 13 years ago
Current Treatment Strategies for Age-Related Ocular Conditionsover 13 years ago
Overview of Age-Related Ocular ConditionsAdvertisement
Related to this article
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Cleveland roundtable panelists across 4 disease states name access, not evidence, as the shared barrier to care.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Inconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
3
Medicaid Obesity GLP-1 Coverage May Offset Some Diabetes-Labeled Use
4
FAQ: How Payers Can Close HIV Prevention and PrEP Access Gaps
5